An Open-label, Randomized, Multi-center, Parallel-Group Clinical Trial Comparing the Efficacy and Safety of Mylan's Insulin Glargine With Lantus in Type 1 Diabetes Mellitus Patients: An Extension Study
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 14 Jun 2017
At a glance
- Drugs Insulin glargine (Primary)
- Indications Type 1 diabetes mellitus
- Focus Registrational; Therapeutic Use
- Sponsors Mylan
- 10 Jun 2017 Biomarkers information updated
- 03 Jun 2017 This trial has been completed Germany.
- 04 May 2017 This study has been completed in Czech Republic (End date 2017-03-09) as per European Clinical Trials Database record.